1. Senoh, S., Witkop, B., Creveling, C. R., and Udenfriend, S. (1959) 2,4,5-Trihydroxyphenethylamine, a new metabolite of 3,4-dihydroxyphenethylamine. J. Am. Chem. Soc. 81, 1768, 1769.
2. Porter, C. C., Totaro, J. A., and Stone, C. A. (1963) Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice. J. Pharmacol. Exp. Ther. 140, 308–316.
3. Laverty, R. and Taylor, K. M. (1970) Effects of intraventricular 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine) on rat behaviour and brain catecholamine metabolism. Br. J. Pharmacol. 40, 836–846.
4. Tranzer, J. P. and Thoenen, H. (1967) Ultramorphologische veranderungen der sympa-tischen nervendigunden der katze nach vorbehandlung mit 5- and 6-hydroxydopamin. Naunyn-Schmiedeberg’s Arch. Pharmacol. Exp. Pathol. 2257, 343, 344.
5. Tranzer, J. P. and Thoenen, H. (1968) An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia
24, 155, 156.